AVIR

AVIR Operating Cash Flow (Statement)

-$152.07MTTM · USD

Period ending:

AVIR FY Cash from OperationsUSD
AVIR FY Cash from Operations2018-12-31: -$7.91M2019-12-31: -$12.81M2020-12-31: $296.73M2021-12-31: -$87.01M2022-12-31: -$120.98M2023-12-31: -$85.40M2024-12-31: -$135.50M2025-12-31: -$132.03M$296.73M-$135.50M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVIR operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Atea Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-132,031,000
-135,499,000
-85,395,000
-120,982,000
-87,005,000
296,734,000
-12,814,000
-7,908,000

Compare operating cash flow (statement)

All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.